Harry’s and Coterie owner Mammoth Brands has ambitions to be the next CPG giant
Mammoth Brands wants to take on traditional consumer packaged goods companies, armed with a portfolio of disruptors in the personal ...
Tag: Hims & Hers Health Inc
The Nasdaq’s win streak, Netflix earnings, another AI pivot and more in Morning Squawk
1. Peace talksUS President Donald Trump speaks to members of the media on the South Lawn of the White House ...
CNBC Daily Open: Amazon’s projected capex dwarfs that of its peers — which have already spooked markets
The logo and lettering of online retailer Amazon can be seen on the façade of Amazon Germany's headquarters. Sven Hoppe ...
Where the blockbuster weight loss drug market stands today — and what’s coming next
A combination image shows an injection pen of Zepbound, Eli Lilly's weight loss drug, and boxes of Wegovy, made by ...
Eli Lilly and Novo Nordisk stocks fall as Trump says he wants $150 price for GLP-1s
Shares of Eli Lilly and Novo Nordisk dropped Friday, after President Donald Trump said his administration aims to cut the ...
Hims & Hers to acquire European telehealth platform in global expansion
The Hims logo arranged on a smartphone in New York, US, on Wednesday, Feb. 12, 2025. Bloomberg | Bloomberg | Getty ...
Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 18%
The "Wegovy" brand slimming syringe is sold in the Achat pharmacy in Mitte. The "Wegovy" slimming syringe has been available ...
Hims & Hers shares rise as company adds new weight-loss medications to platform
The Hims app arranged on a smartphone in New York on Feb. 12, 2025.Gabby Jones | Bloomberg | Getty ImagesHims ...
Zepbound copycats remain online despite FDA ban
This week was supposed to mark the end of compounding pharmacies making copycat versions of Eli Lilly's weight-loss drug Zepbound ...
Hims & Hers shares tumble after company misses on margin, says may stop selling some weight loss drugs
Hims & Hers Health shares plunged 18% in extended trading on Monday after investors looked past better-than-expected revenue and earnings ...
